19-55593136-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032836.3(FIZ1):c.805G>A(p.Ala269Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000797 in 1,204,214 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000062 ( 1 hom. )
Consequence
FIZ1
NM_032836.3 missense
NM_032836.3 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: -0.128
Genes affected
FIZ1 (HGNC:25917): (FLT3 interacting zinc finger 1) This gene encodes zinc finger protein, which interacts with a receptor tyrosine kinase involved in the regulation of hematopoietic and lymphoid cells. This gene product also interacts with a transcription factor that regulates the expression of rod-specific genes in retina. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004875958).
BS2
High AC in GnomAd4 at 31 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FIZ1 | NM_032836.3 | c.805G>A | p.Ala269Thr | missense_variant | 3/3 | ENST00000221665.5 | NP_116225.2 | |
FIZ1 | XM_005259352.5 | c.805G>A | p.Ala269Thr | missense_variant | 3/3 | XP_005259409.1 | ||
FIZ1 | XM_047439564.1 | c.805G>A | p.Ala269Thr | missense_variant | 2/2 | XP_047295520.1 | ||
FIZ1 | XM_011527426.3 | c.787G>A | p.Ala263Thr | missense_variant | 2/2 | XP_011525728.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FIZ1 | ENST00000221665.5 | c.805G>A | p.Ala269Thr | missense_variant | 3/3 | 1 | NM_032836.3 | ENSP00000221665.2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 31AN: 147876Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
31
AN:
147876
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00101 AC: 4AN: 3944Hom.: 0 AF XY: 0.000402 AC XY: 1AN XY: 2490
GnomAD3 exomes
AF:
AC:
4
AN:
3944
Hom.:
AF XY:
AC XY:
1
AN XY:
2490
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000615 AC: 65AN: 1056230Hom.: 1 Cov.: 36 AF XY: 0.0000806 AC XY: 41AN XY: 508820
GnomAD4 exome
AF:
AC:
65
AN:
1056230
Hom.:
Cov.:
36
AF XY:
AC XY:
41
AN XY:
508820
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000209 AC: 31AN: 147984Hom.: 0 Cov.: 33 AF XY: 0.000263 AC XY: 19AN XY: 72120
GnomAD4 genome
AF:
AC:
31
AN:
147984
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
72120
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.805G>A (p.A269T) alteration is located in exon 3 (coding exon 2) of the FIZ1 gene. This alteration results from a G to A substitution at nucleotide position 805, causing the alanine (A) at amino acid position 269 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of phosphorylation at A269 (P = 0.0035);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at